journal article·2019-12-04Open access

Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183

Tao Shen, Xianshuo Cheng, Xin Liu, Cuifeng Xia, Hongtao Zhang, Dingguo Pan, Xuan Zhang, Yunfeng Li

Abstract

Background: CircRNA circ_0026344 was previously revealed as a tumour-suppressive gene in colorectal cancer (CRC) progression. The purpose of this research was to investigate the role of circ_0026344 in CRC cells metastasis induced by chemokines.Methods: Two human CRC cell lines SW480 and Caco-2 were treated by CCL20 and CXCL8. Cell proliferation, migration/invasion, expression of epithelial-mesenchymal transition (EMT) inducers and the expression of circ_0026344 were measured using sulforhodamine B assay, Transwell chamber, western blot and qRT-PCR, respectively. The effects of circ_0026344 on CRC cells migration/invasion and the expression of EMT inducers were evaluated. Moreover, the downstream miRNA and signalling pathways of circ_0026344 were studied.Results: CCL20 and CXCL8 synergized to facilitate the proliferation, migration and invasion of CRC cells. At the meantime, E-cadherin was downregulated, whereas N-cadherin, Vimentin and Snail were up-regulated by CCL20 and CXCL8 co-stimulation, which was accompanied by the mobilization of PI3K/AKT/ERK signalling. More interestingly, the expression of circ_0026344 was down-regulated by CCL20 and CXCL8 co-stimulation. Silence of circ_0026344 increased the migratory and invasive capacities of CRC cells and increased EMT process as well. Overexpression of circ_0026344 led to a contrary impact. miR-183 was negatively regulated by circ_0026344, and the inhibitory effects of circ_0026344 overexpression on Wnt/β-catenin pathway were reversed when miR-183 was overexpressed.Conclusion: Overexpression of circ_0026344 restrained CRC metastasis and EMT induced by CCL20 and CXCL8 synergistical treatment. miR-183 was a downstream effector of circ_0026344, and the anti-tumour function of circ_0026344 might be involved in the repressed Wnt/β-catenin signalling.HighlightsCCL20 and CXCL8 synergize to decrease the expression of circ_0026344;Silence of circ_0026344 promotes CRC cells migration, invasion and EMT process;miR-183 is a downstream effector of circ_0026344.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Circular RNAs in diseases · MicroRNA in disease regulation · Cancer-related molecular mechanisms research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Colorectal Surgery, The Third Affiliated Hospital of Kunming Medical University

Tumor Institute, The Third Affiliated Hospital of Kunming Medical University

Funding

Yunnan Provincial Health and Family Planning Commission Internal Research Project · Yunnan Provincial Science and Technology Department- Kunming Medical University Joint Research Project

References (35)

Show source-provided references
1. 10.3322/caac.2122010.3322/caac.21220 ↗
2. 10.1016/j.cell.2012.04.04210.1016/j.cell.2012.04.042 ↗
3. 10.18632/oncotarget.493510.18632/oncotarget.4935 ↗
4. 10.1042/BSR2018058010.1042/BSR20180580 ↗
5. 10.1016/j.canlet.2015.02.02110.1016/j.canlet.2015.02.021 ↗
6. 10.3892/mco.2015.66510.3892/mco.2015.665 ↗
7. 10.3892/or.2013.258010.3892/or.2013.2580 ↗
8. 10.1002/ijc.2446810.1002/ijc.24468 ↗
9. 10.3892/or.2017.545310.3892/or.2017.5453 ↗
10. 10.1016/j.canlet.2014.03.00810.1016/j.canlet.2014.03.008 ↗
11. 10.1016/j.semcancer.2018.12.00210.1016/j.semcancer.2018.12.002 ↗
12. 10.2174/156652321866618110914275610.2174/1566523218666181109142756 ↗
13. 10.1016/j.bbrc.2018.06.08910.1016/j.bbrc.2018.06.089 ↗
14. 10.1016/S0092-8674(04)00045-510.1016/S0092-8674(04)00045-5 ↗
15. 10.1080/15384047.2014.100232710.1080/15384047.2014.1002327 ↗
16. 10.1016/j.ccr.2006.01.02510.1016/j.ccr.2006.01.025 ↗
17. 10.1111/j.1525-142X.2007.00217.x10.1111/j.1525-142X.2007.00217.x ↗
18. 10.1158/1078-0432.CCR-11-024210.1158/1078-0432.CCR-11-0242 ↗
19. 10.1016/j.biocel.2012.12.01010.1016/j.biocel.2012.12.010 ↗
20. 10.2353/jmoldx.2010.09015410.2353/jmoldx.2010.090154 ↗
21. 10.1016/j.gene.2013.06.00610.1016/j.gene.2013.06.006 ↗
22. 10.1097/MEG.000000000000000210.1097/MEG.0000000000000002 ↗
23. 10.18632/oncotarget.1915410.18632/oncotarget.19154 ↗
24. 10.3892/or.2016.463110.3892/or.2016.4631 ↗
25. 10.3892/mmr.2015.337610.3892/mmr.2015.3376 ↗
26. 10.1016/S0140-6736(13)61649-910.1016/S0140-6736(13)61649-9 ↗
27. 10.1073/pnas.73.11.385210.1073/pnas.73.11.3852 ↗
28. 10.1016/j.biopha.2018.10.15910.1016/j.biopha.2018.10.159 ↗
29. 10.1002/jcb.2735510.1002/jcb.27355 ↗
30. 10.1016/j.biopha.2017.11.05010.1016/j.biopha.2017.11.050 ↗
31. 10.3892/or.2015.397110.3892/or.2015.3971 ↗
32. 10.1126/scisignal.200518910.1126/scisignal.2005189 ↗
33. 10.1016/j.bbrc.2018.01.17010.1016/j.bbrc.2018.01.170 ↗
34. Chen Y, Song W. Wnt/catenin beta1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer. Oncol Lett. 2018;15(4):4451–4456.
35. 10.1016/j.cellsig.2014.02.00310.1016/j.cellsig.2014.02.003 ↗